NCT04790045View on ClinicalTrials.gov

Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG

Venetoclax

Core-needle biopsy to be performed before starting treatment in patients candidates to venetoclax-based regimens

All Listed Sponsors

lead

Paolo Ghia

OTHER